Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization. (Q53069345)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 May 2010

Language	Label	Description	Also known as
English	Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization.	scientific article published on 25 May 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

0 references

Streptococcus mutans

object named as

Streptococcus mutans

1 reference

based on heuristic

inferred from title

author name string

Yu Hong Li

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

ShengFu Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

MinQuan Du

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

Zhuan Bian

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

Zhi Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

Ming Wen Fan

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

language of work or name

0 references

publication date

25 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

28

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

32

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

5370-5376

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

Secretory immunity in defense against cariogenic mutans streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Correlation among mutans streptococci counts, dental caries, and IgA to Streptococcus mutans in saliva

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Enhancement of salivary IgA response to a DNA vaccine against Streptococcus mutans wall-associated protein A in mice by plasmid-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Role of secretory antibodies in the defence against infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Construction of a sIgA-enhancing anti-Porphyromonas gingivalis FimA vaccine and nasal immunization in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Current status of a mucosal vaccine against dental caries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Immunization against dental caries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Immunogenicity of CTLA4 fusion anti-caries DNA vaccine in rabbits and monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Towards progress on DNA vaccines for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Strategies for effective naked-DNA vaccination against infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Nasal immunization of humans with dehydrated liposomes containing Streptococcus mutans antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Vaccination strategies for mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Mucosal immunosenescence: new developments and vaccines to control infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Improvement of the systemic prime/oral boost strategy for systemic and local responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Comparison of murine nasal-associated lymphoid tissue and Peyer's patches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.067

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.04.067

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/20573581

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53069345&oldid=1767187765"